Virtual journey: ATTR amyloidosis

Written by Jameson Kowalczyk. Medically reviewed in March 2025.

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

Strategies for caregivers of people with ATTR-CM when a treatment plan involves taking multiple medications.

Strategies to promote communication among the different healthcare providers you need to work with to treat ATTR-CM.

How ATTR cardiomyopathy may affect mental health and four strategies for seeking support.

Understanding quality of life and why it’s an important consideration when living with and treating ATTR-CM.

A guide to three different types of amyloidosis, with a look at causes and underlying conditions.

Living with and treating ATTR amyloidosis